Publications by authors named "Adrien Coutu"
Article Synopsis
- * Among 181 AD patients, 14.9% had conjunctivitis at the start, with most seeing improvement by week 16, while 18.7% developed dupilumab-induced blepharoconjunctivitis, primarily as new cases.
- * Key risk factors linked to dupilumab-induced blepharoconjunctivitis included having AD on the head and neck, erythroderma, and existing dry eye syndrome, though baseline conjunctivitis severity wasn't a significant factor.
Purpose: The purpose of this study was to assess the medical history of adenoviral keratoconjunctivitis (AK) and subepithelial infiltrates (SEIs) among French ophthalmologists and orthoptists and the frequency of unreported occupational diseases. We also described short-term and long-term consequences of AK and evaluated associated factors.
Methods: The REDCap questionnaire was diffused online several times over 7 consecutive months, from October 2019 to May 2020, through mailing lists (French Society of Ophthalmology, residents, and hospital departments), social networks, and by word of mouth.
Purpose: To evaluate the outcome of SPOT scleral lenses in the management of irregular astigmatism in patients with corneal ectasia and penetrating keratoplasty. Second, we analyzed patients' characteristics and tolerance, comfort, and geometries of fitted lenses.
Method: Over a 5-year period, we included patients experiencing irregular astigmatism fitted with SPOT scleral contact lenses, from the University Hospital of Clermont-Ferrand, France.
Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis.
J Allergy Clin Immunol
September 2021
Background: Vernal keratoconjunctivitis (VKC) is a severe type of allergic conjunctivitis for which treatment strategies are still under debate.
Objectives: This study sought to conduct a systematic review and meta-analysis to evaluate the efficacy of medical treatments for VKC.
Methods: The PubMed, Cochrane Library, Embase, and ScienceDirect databases were searched to assess the efficacy of treatments for VKC.